Long-Term Follow-up of Enhanced Holter- Electrocardiography Monitoring in Acute Ischemic Stroke
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Prolonged electrocardiography (ECG)-monitoring in stroke patients improves the detection of paroxysmal atrial fibrillation (pAF). However, most randomized studies only had short follow-up. We aimed to provide 3-year follow-up data for AF detection and stroke recurrence risk. Methods We randomized 402 patients aged ≥60 years with acute ischemic strokes without AF to either enhanced and prolonged monitoring (EPM; 3×10-day Holter-ECG-monitoring) or standard-of-care (≥24 hours ECG-monitoring). The endpoint of the current analysis was AF within 36 months analyzed by intention to treat. Long-term follow-up was performed for 36 months. Results Two hundred and seventy-four patients (80%) participated in the extended follow-up(median duration of follow-up was 36 months [interquartile range, 12 to 36]). During the first 6 months, more AF was documented in the EPM arm compared to the control arm (13.5% vs. 5.1%; 95% confidence interval, 2.9% to 14.4%; P=0.004). During months 6 to 36, AF was less detected in the EPM intervention arm than in the control arm (2.0% vs. 7.3%; 95% confidence interval, 0.7% to 9.9%; P=0.028). Overall, the detection rate of AF within 36 months was numerically higher within the EPM group (15.0% vs. 11.1%, P=0.30). Numerically less patients in the EPM arm had recurrent ischemic strokes (5.5% vs. 9.1%, P=0.18), transient ischemic attacks (3.0% vs. 4.5%, P=0.44) or died (4.5% vs. 6.6%, P=0.37). Conclusions Enhanced and prolonged ECG monitoring increased AF detection during the first six months, but there was significantly more clinical AF during months 6 to 36 observed in the usual-care arm. This suggests that EPM leads to an earlier detection of clinically relevant AF.
Abstract
Background and Purpose Prolonged electrocardiography (ECG)-monitoring in stroke patients improves the detection of paroxysmal atrial fibrillation (pAF). However, most randomized studies only had short follow-up. We aimed to provide 3-year follow-up data for AF detection and stroke recurrence risk. Methods We randomized 402 patients aged ≥60 years with acute ischemic strokes without AF to either enhanced and prolonged monitoring (EPM; 3×10-day Holter-ECG-monitoring) or standard-of-care (≥24 hours ECG-monitoring). The endpoint of the current analysis was AF within 36 months analyzed by intention to treat. Long-term follow-up was performed for 36 months. Results Two hundred and seventy-four patients (80%) participated in the extended follow-up(median duration of follow-up was 36 months [interquartile range, 12 to 36]). During the first 6 months, more AF was documented in the EPM arm compared to the control arm (13.5% vs. 5.1%; 95% confidence interval, 2.9% to 14.4%; P=0.004). During months 6 to 36, AF was less detected in the EPM intervention arm than in the control arm (2.0% vs. 7.3%; 95% confidence interval, 0.7% to 9.9%; P=0.028). Overall, the detection rate of AF within 36 months was numerically higher within the EPM group (15.0% vs. 11.1%, P=0.30). Numerically less patients in the EPM arm had recurrent ischemic strokes (5.5% vs. 9.1%, P=0.18), transient ischemic attacks (3.0% vs. 4.5%, P=0.44) or died (4.5% vs. 6.6%, P=0.37). Conclusions Enhanced and prolonged ECG monitoring increased AF detection during the first six months, but there was significantly more clinical AF during months 6 to 36 observed in the usual-care arm. This suggests that EPM leads to an earlier detection of clinically relevant AF.
참고문헌 (24)
- Tu HT, "Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation", Int J Stroke, 10, pp.534~540 (2015)
- Kolominsky-Rabas PL, "Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and longterm survival in ischemic stroke subtypes: a population-based study", Stroke, 32, pp.2735~2740 (2001)
- Freedman B, "Stroke prevention in atrial fibrillation", Lancet, 388, pp.806~817 (2016)
- Gladstone DJ, "Atrial fibrillation in patients with cryptogenic stroke", N Engl J Med, 370, pp.2467~2477 (2014)
- Sanna T, "Cryptogenic stroke and underlying atrial fibrillation", N Engl J Med, 370, pp.2478~2486 (2014)
- Wachter R, "Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial", Lancet Neurol, 16, pp.282~290 (2017)
- Reiffel JA, "Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population : the REVEAL AF Study", JAMA Cardiol, 2, pp.1120~1127 (2017)
- Wilson JMG, "Principles and Practice of Screening for Disease", World Health Organization, ~ (1968)
- Weber-Krüger M, "Finding atrial fibrillation in stroke patients:randomized evaluation of enhanced and prolonged Holter monitoring: Find-AF(RANDOMISED). Rationale and design", Am Heart J, 168, pp.438~445 (2014)
- European Heart Rhythm Association, "Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)", Eur Heart J, 31, pp.2369~2429 (2010)
- Gray RJ, "A class of K-sample tests for comparing the cumulative incidence of a competing risk", Ann Stat, 16, pp.1141~1154 (1988)
- Brachmann J, "Uncovering atrial fibrillation beyond shortterm monitoring in cryptogenic stroke patients: three-year results from the cryptogenic stroke and underlying atrial fibrillation trial", Circ Arrhythm Electrophysiol, 9, pp.e003333~ (2016)
- Weber-Krüger M, "Relevance of supraventricular runs detected after cerebral ischemia", Neurology, 89, pp.1545~1552 (2017)
- Van Gelder IC, "Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT", Eur Heart J, 38, pp.1339~1344 (2017)
- Hart RG, "Rivaroxaban for stroke prevention after embolic stroke of undetermined source", N Engl J Med, 378, pp.2191~2201 (2018)
- Diener HC, "Dabigatran for prevention of stroke after embolic stroke of undetermined source", N Engl J Med, 380, pp.1906~1917 (2019)
- Tsivgoulis G, "Prolonged cardiac rhythm monitoring and secondary stroke prevention in patients with cryptogenic cerebral ischemia", Stroke, 50, pp.2175~2180 (2019)
- Wachter R, "Age-dependent yield of screening for undetected atrial fibrillation in stroke patients : the Find-AF study", J Neurol, 260, pp.2042~2045 (2013)
- Stahrenberg R, "Transthoracic echocardiography to rule out paroxysmal atrial fibrillation as a cause of stroke or transient ischemic attack", Stroke, 42, pp.3643~3645 (2011)
- Weber-Krüger M, "Excessive supraventricular ectopic activity is indicative of paroxysmal atrial fibrillation in patients with cerebral ischemia", PLoS One, 8, pp.e67602~ (2013)
- Wachter R, "Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia : the Find-AF study", PLoS One, 7, pp.e34351~ (2012)
- Wasser K, "Brain natriuretic peptide and discovery of atrial fibrillation after stroke : a subanalysis of the Find-AFRANDOMISED Trial", Stroke, 51, pp.395~401 (2020)
- Haeusler KG, "Expert opinion paper on atrial fibrillation detection after ischemic stroke", Clin Res Cardiol, 107, pp.871~880 (2018)
- Haeusler KG, "Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany : results from the German AFNET registry", BMC Neurol, 15, pp.129~ (2015)